Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

Repligen (RGEN)

Repligen Corp
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:RGEN
DateTimeSourceHeadlineSymbolCompany
07/01/202512:30GlobeNewswire Inc.Repligen Corporation to Present at 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:RGENRepligen Corp
06/01/202512:30GlobeNewswire Inc.Repligen Launches the CTech™ SoloVPE® PLUS SystemNASDAQ:RGENRepligen Corp
16/12/202413:11PR Newswire (US)BioLife Solutions Appoints Tony J. Hunt to its Board of DirectorsNASDAQ:RGENRepligen Corp
12/12/202412:30GlobeNewswire Inc.Repligen Announces Publication of the Company’s 2023 Corporate Sustainability ReportNASDAQ:RGENRepligen Corp
09/12/202412:30GlobeNewswire Inc.Repligen Launches Novel AVIPure® dsRNA Resin in OPUS® Pre-packed ColumnsNASDAQ:RGENRepligen Corp
06/12/202401:26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RGENRepligen Corp
22/11/202421:52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RGENRepligen Corp
21/11/202420:52Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:RGENRepligen Corp
21/11/202419:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RGENRepligen Corp
21/11/202418:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RGENRepligen Corp
20/11/202419:29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RGENRepligen Corp
18/11/202417:10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RGENRepligen Corp
18/11/202417:08Edgar (US Regulatory)Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]NASDAQ:RGENRepligen Corp
18/11/202417:07Edgar (US Regulatory)Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]NASDAQ:RGENRepligen Corp
18/11/202417:06Edgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]NASDAQ:RGENRepligen Corp
18/11/202417:02Edgar (US Regulatory)Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]NASDAQ:RGENRepligen Corp
12/11/202421:22Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:RGENRepligen Corp
12/11/202416:44Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:RGENRepligen Corp
12/11/202412:44Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RGENRepligen Corp
12/11/202412:30GlobeNewswire Inc.Repligen Reports Third Quarter 2024 Financial ResultsNASDAQ:RGENRepligen Corp
05/11/202412:30GlobeNewswire Inc.Repligen Corporation to Present at Upcoming Investor ConferencesNASDAQ:RGENRepligen Corp
31/10/202411:30GlobeNewswire Inc.Repligen to Report Third Quarter 2024 Financial ResultsNASDAQ:RGENRepligen Corp
23/10/202421:04Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:RGENRepligen Corp
24/09/202411:30GlobeNewswire Inc.Repligen Opens Training & Innovation Center to Elevate Customer ExperienceNASDAQ:RGENRepligen Corp
18/09/202420:21Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RGENRepligen Corp
12/09/202415:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RGENRepligen Corp
10/09/202420:03Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:RGENRepligen Corp
05/09/202400:41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RGENRepligen Corp
04/09/202423:25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RGENRepligen Corp
23/08/202411:30GlobeNewswire Inc.Repligen Corporation to Present at Wells Fargo Healthcare ConferenceNASDAQ:RGENRepligen Corp
 Showing the most relevant articles for your search:NASDAQ:RGEN